SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-009345
Filing Date
2023-03-28
Accepted
2023-03-28 08:15:22
Documents
17
Period of Report
2023-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aadi-20230324.htm   iXBRL 8-K 34684
2 EX-99.1 aadi-20230328xex991.htm EX-99.1 116677
3 EX-99.2 aadi-20230327xex992xpressr.htm EX-99.2 12594
7 aadilogo-pressrelease1.jpg GRAPHIC 11355
8 aadilogo-pressreleasea.jpg GRAPHIC 11355
9 pressreleasea.jpg GRAPHIC 8927
  Complete submission text file 0001628280-23-009345.txt   340781

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20230324.xsd EX-101.SCH 1890
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20230324_lab.xml EX-101.LAB 24849
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20230324_pre.xml EX-101.PRE 13038
11 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20230324_htm.xml XML 4284
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 23766272
SIC: 2834 Pharmaceutical Preparations